← Back to Search

Expressive Writing for Emotional Distress

N/A

Recruiting

Led By Elliot A Tebbe, PhD, LP

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 3 months

Awards & highlights

Study Summary

This trial offers an expressive writing intervention to reduce stigma and increase well-being for trans and nonbinary people. Participation is 3 months.

Who is the study for?

This trial is for trans and nonbinary individuals over 18 who can read and write English, have access to a device for surveys and writing tasks, but not experiencing severe psychological distress or identifying as cisgender.Check my eligibility

What is being tested?

The study tests if expressive writing can reduce anti-TNB stigma and improve well-being. Participants will engage in different forms of writing like gratitude letters, daily event reflections, or responding to vignettes over three months.See study design

What are the potential side effects?

There are no direct physical side effects expected from the interventions since they involve writing activities. However, discussing sensitive topics may potentially cause temporary emotional discomfort.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Amount of time spent writing

Assess the acceptability of expressive writing intervention through qualitative data

Assess the feasibility of expressive writing intervention by recording the number of attended writing sessions for each participant.

+3 more

Secondary outcome measures

Change in Gender Minority Stress and Resilience (GMSR)

Change in perception of social support

Change in psychological well-being

+4 more

Trial Design

3Treatment groups

Experimental Treatment

Group I: TNB Identity Affirmation (IA) ConditionExperimental Treatment1 Intervention

Participants in the IA only intervention condition will receive the same prompt for all four days of writing, a design used in expressive writing interventions to allow for deeper and continued reflection into specific thoughts and emotions.

Group II: IA + Strengthening Social Connections (SSC) ConditionExperimental Treatment2 Interventions

For participants in the IA+SSC condition, participants will complete the IA intervention on the first three days. On the fourth day, participants will be directed to compose a brief letter.

Group III: Control ConditionExperimental Treatment1 Intervention

Expressive writing assignment, without prompts.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor

1,189 Previous Clinical Trials

3,169,396 Total Patients Enrolled

1 Trials studying Emotional Distress

10,000 Patients Enrolled for Emotional Distress

Elliot A Tebbe, PhD, LPPrincipal InvestigatorUniversity of Wisconsin, Madison

Media Library

Expressive Writing Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05782868 — N/A

Emotional Distress Research Study Groups: TNB Identity Affirmation (IA) Condition, IA + Strengthening Social Connections (SSC) Condition, Control Condition

Emotional Distress Clinical Trial 2023: Expressive Writing Intervention Highlights & Side Effects. Trial Name: NCT05782868 — N/A

Expressive Writing Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05782868 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any fresh participants being accepted for the research project?

"According to clinicaltrials.gov, this medical trial is not presently recruiting participants. This study was initially advertised on March 1st 2023 and the last update occurred on the 21st of that month. Nevertheless, 33 other trials are actively looking for volunteers right now."

Answered by AI

What purpose does this exploration endeavor to achieve?

"The primary objective of this research is to gauge the feasibility of expressive writing therapy by measuring the number of attended sessions over a seven-day period. Secondary outcomes include shifts in depression, anxiety and stress levels as indicated on the Depression Anxiety Stress Scale (DASS), changes in psychological well-being as determined through Psychological Well-Being Scale (PWB) scores, and alterations to Gender Minority Stress and Resilience (GMSR)."

Answered by AI